Auster Martin — SEC Form 4 filings
SEC reporting owner CIK 1875786. 2 Form 4 filings on record with FilingPulse; latest filed 2024-04-03.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2024-03-29 to 2024-04-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,405 shares, $7,592 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 1,405 shares @ $5.40 ($7,592) in Ventyx Biosciences, Inc., filed 2024-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) | CHIEF FINANCIAL OFFICER | 2 | — | 1 leg · 1,405 sh · $7,592 | 2 |
Form 4 filings — Auster Martin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-04-03 | 4 | Ventyx Biosciences, Inc. (VTYX) | Sale (S): 1,405 @ $5.40 | EDGAR |
| 2024-03-29 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 4,531 @ $0 · Option exercise (M): 4,531 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1875786 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →